Event calendar
-
Dec 13, 2011 - Novartis Oncology key data
Conference call - Audio webcast only
Hervé Hoppenot
President, Novartis OncologyAlessandro Riva, MD
Global Head, Novartis Oncology Global Development & Global Medical Affairs -
Nov 30, 2011 - Société Générale Premium Review
-
Nov 10, 2011 - Credit Suisse Healthcare Conference
-
Oct 25, 2011 - Third quarter 2011 results
- Oct 21, 2011 - Gilenya, one year after launch / ECTRIMS 2011
- Sep 27, 2011 - Afinitor phase III data in ER+ HER2- breast cancer (BOLERO-2)
-
Sep 13, 2011 - Novartis Strategy and Innovation Forum II - Alcon update
London, UK
Disclaimer for presentations (20 KB)
Delivering on our strategic objectives Joseph Jimenez - CEO, Novartis (0.6 MB)
Alcon: Creating value Robert Karsunky - Chief Financial Officer, Alcon (0.2 MB)
Alcon R&D: Glimpse into the Future Sabri Markabi, MD - Chief Medical Officer, Alcon (1.0 MB)
-
Jul 19, 2011 - Second quarter 2011 results
-
Jun 30, 2011 - Nomura Healthcare Conference
-
Jun 07, 2011 - Goldman Sachs 32nd Annual Global Healthcare Conference
Rancho Palos Verdes, California, USA
Jon Symonds
Chief Financial Officer -
Jun 07, 2011 - American Society of Clinical Oncology: news on the Novartis Oncology portfolio
Chicago, USA
Hervé Hoppenot
President, Novartis OncologyAlessandro Riva
Global Head, Novartis Oncology Global Development & Global Medical Affairs -
May 25, 2011 - UBS Global Specialty Pharmaceuticals Conference
London, UK
Isabella Zinck
Investor Relations -
May 23, 2011 - Deutsche Bank Access Asia Conference 2011
-
May 19, 2011 - Exane Healthcare Conference
Paris, France
Subhanu Saxena
Global Head Product Strategy & Commercialization -
May 18, 2011 - Citi Nordic Symposium
- May 18, 2011 - Restated Novartis divisional structure following the Alcon merger
-
May 17, 2011 - Deutsche Bank Swiss Equities Conference
-
May 03, 2011 - Deutsche Bank Healthcare Conference
Boston, United States
André Wyss
Head Pharma North America
President, Novartis Pharmaceuticals Corporation -
Apr 19, 2011 - First quarter 2011 results
Basel, Switzerland
Media release
-
Apr 08, 2011 - Extraordinary General Meeting
Basel, Switzerland
Media release
Minutes of the Extraordinary General Meeting (German only) (0.5 MB)
The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
